Impact of cellular therapies and tissue bioengineering on skin regeneration for patients with refractory chronic ulcers: a systematic review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20250991Keywords:
Cellular therapies, Tissue bioengineering, Skin regeneration techniques, Skin ulcersAbstract
Cellular therapies and tissue bioengineering show promise in treating chronic ulcers, including diabetic foot, venous, and pressure ulcers. These conditions affect over 2% of the population and pose serious health risks, including infection and amputation. Conventional treatments often fail, leading to prolonged healing times and increased healthcare costs. This systematic review assesses the effectiveness of regenerative approaches by analyzing their impact on wound closure, skin thickness, pain-free walking, and the ankle–brachial index. A thorough search in PubMed, Embase, and Cochrane Library identified relevant randomized controlled trials and systematic reviews. Studies using stem cells, fibroblasts, keratinocytes, bioengineered skin, and 3D bioprinting were included. Two independent reviewers extracted data and assessed study quality. A random-effects model was applied to account for variability. Findings show that cellular therapies and tissue bioengineering significantly improve wound healing. The systematic review revealed higher wound closure rates (RD=0.36, p<0.01), increased skin thickness (SMD=0.65, p<0.05), and greater pain-free walking distance (SMD=1.27, p<0.001). Adverse events were minimal, with no significant differences between intervention and control groups. These therapies enhance healing and tissue regeneration, supporting their use in clinical practice. Further research is needed to refine treatment protocols and ensure long-term safety and effectiveness.
Metrics
References
Falanga V, Isseroff RR, Soulika AM, Romanelli M, Margolis D, Kapp S, et al. Chronic wounds. Nat Rev Dis Primers. 2022;8(1):50. DOI: https://doi.org/10.1038/s41572-022-00377-3
Armstrong DG, Tan TW, Boulton AJ, Bus SA. Diabetic foot ulcers: a review. JAMA. 2023;330(1):62-75. DOI: https://doi.org/10.1001/jama.2023.10578
Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regeneration Internet. 2009;17(6):763-71. DOI: https://doi.org/10.1111/j.1524-475X.2009.00543.x
Jaul E, Barron J, Rosenzweig JP, Menczel J. An overview of co-morbidities and the development of pressure ulcers among older adults. BMC Geriatrics. 2018;18:1-1. DOI: https://doi.org/10.1186/s12877-018-0997-7
Wang X, Yuan CX, Xu B, Yu Z. Diabetic foot ulcers: Classification, risk factors and management. World J Diabetes. 2022;13(12):1049. DOI: https://doi.org/10.4239/wjd.v13.i12.1049
Kirsner RS, Vivas AC. Lower‐extremity ulcers: diagnosis and management. Br J Dermatol. 2015;173(2):379-90. DOI: https://doi.org/10.1111/bjd.13953
Van de Vyver M, Idensohn PJ, Niesler CU. A regenerative approach to the pharmacological management of hard-to-heal wounds. Biochimie. 2022;196:131-42. DOI: https://doi.org/10.1016/j.biochi.2022.01.006
Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care. 2015;4(9):560-82. DOI: https://doi.org/10.1089/wound.2015.0635
Bhardwaj N, Chouhan D, B. Mandal B. Tissue engineered skin and wound healing: current strategies and future directions. Curr Pharm Design. 2017;23(24):3455-82. DOI: https://doi.org/10.2174/1381612823666170526094606
Las Heras K, Igartua M, Santos-Vizcaino E, Hernandez RM. Cell-based dressings: A journey through chronic wound management. Biomat Adv. 2022;135:212738. DOI: https://doi.org/10.1016/j.bioadv.2022.212738
Tan PC, Chao PC, Cheng C, Chen CH, Huang RL, Zhou SB, et al. A randomized, controlled clinical trial of autologous stromal vascular fraction cells transplantation to promote mechanical stretch-induced skin regeneration. Stem Cell Res Ther. 2021;12(1):243. DOI: https://doi.org/10.1186/s13287-021-02318-5
Sharma AD, Jarman EH, Fox PM. Scoping review of hydrogel therapies in the treatment of diabetic chronic wounds. Plast Reconstr Surg Glob Open. 2023;11(5):e4984. DOI: https://doi.org/10.1097/GOX.0000000000004984
Mudgal SK, Kumar S, Gaur R, Singh H, Saikia D, Varshney S, et al. Effectiveness of stem cell therapy for diabetic foot ulcers: A systematic review and GRADE compliant bootstrapped meta-analysis of randomized clinical trials. Int J Low Extrem Wounds. 2024;15347346241227530. DOI: https://doi.org/10.1177/15347346241227530
Stone RC, Stojadinovic O, Sawaya AP, Glinos GD, Lindley LE, Pastar I, et al. A bioengineered living cell construct activates metallothionein/zinc/MMP8 and inhibits TGFβ to stimulate remodeling of fibrotic venous leg ulcers. Wound Repair Regen. 2019;28(2):164-76. DOI: https://doi.org/10.1111/wrr.12778
Armstrong DG, Hanft J, Surprenant M, Isaac A, Carter M, Zelen C, Gunasekaran S. Comparing the efficacy of a unique advanced bioengineered Type-I collagen-based skin substitute versus an amnion graft with standard of care in the treatment of non-healing diabetic foot ulcers: A randomized clinical trial. Cureus. 2025;17(1):e78021. DOI: https://doi.org/10.7759/cureus.78021
Armstrong DG, Orgill DP, Galiano R, Glat PM, Didomenico L, Sopko NA, et al. A multicenter, randomized controlled clinical trial evaluating the effects of a novel autologous heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Final analysis. Int Wound J. 2023;20(10):4083-96. DOI: https://doi.org/10.1111/iwj.14301
Marfia G, Navone SE, Di Vito C, Ughi N, Tabano S, Miozzo M, et al. Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds. Organogenesis Internet. 2015;11(4):183-206. DOI: https://doi.org/10.1080/15476278.2015.1126018
Xu Y, Wu X, Zhang Y, Yu Y, Gan J, Tan Q. Engineered artificial skins: Current construction strategies and applications. Engineered Regeneration Internet. 2023;4(4):438-50. DOI: https://doi.org/10.1016/j.engreg.2023.09.001
Downloads
Published
How to Cite
Issue
Section
